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Overlapping roles have been ascribed for T cell anergy, clonal deletion, and regulation in the maintenance of
peripheral immunological tolerance. A measurement of the individual and additive impacts of each of these processes
on systemic tolerance is often lacking. In this report we have used adoptive transfer strategies to tease out the unique
contribution of T cell intrinsic receptor calibration (adaptation) in the maintenance of tolerance to a systemic self-
antigen. Adoptively transferred naı ¨ve T cells stably calibrated their responsiveness to a persistent self-antigen in both
lymphopenic and T cell–replete hosts. In the former, this state was not accompanied by deletion or suppression,
allowing us to examine the unique contribution of adaptation to systemic tolerance. Surprisingly, adapting T cells
could chronically help antigen-expressing B cells, leading to polyclonal hypergammaglobulinemia and pathology, in
the form of mild arthritis. The helper activity mediated by CD40L and cytokines was evident even if the B cells were
introduced after extended adaptation of the T cells. In contrast, in the T cell–replete host, neither arthritis nor
autoantibodies were induced. The containment of systemic pathology required host T cell–mediated extrinsic
regulatory mechanisms to synergize with the cell intrinsic adaptation process. These extrinsic mechanisms prevented
the effector differentiation of the autoreactive T cells and reduced their precursor frequency, in vivo.
Citation: Singh NJ, Chen C, Schwartz RH (2006) The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance. PLoS Biol 4(11): e340. DOI: 10.1371/journal.
pbio.0040340
Introduction
The efﬁcient clonal expansion of pathogen-speciﬁc T cells
plays a crucial role in determining the success of an immune
response against a rapidly replicating infectious challenge.
The ability of this expanded lymphocyte pool to effectively
combat the pathogen also relies on the extent of effector
functions that it acquires and maintains. Differentiated
helper T cells produce cytokines and cell surface ligands that
regulate the subsequent generation of cytotoxic and humoral
responses. This differentiation process is often correlated
with proliferative expansion, but there is evidence to suggest
that the two processes can be independently regulated [1–3].
Subsequent to clearance of the pathogen, most members of
these expanded populations of antigen-speciﬁc lymphocytes
are eliminated and the few that survive often typically
demonstrate better responsiveness.
In cases where a T cell response is initiated against a
chronic nonclearable pathogen or a persistent self-antigen,
the immune system evokes many regulatory mechanisms
aimed at containing the potentially damaging chronic T cell
activity. One such mechanism has been called adaptive
tolerance [4]. This process is a T cell–intrinsic downregula-
tion of responsiveness, likely mediated by the recruitment of
negative feedback in signaling pathways downstream of the T
cell receptor (TCR). The consequent hyporesponsiveness of
the T cell is proportional to the strength of the ambient
antigen presentation and is reversible upon removal from the
antigen-bearing host [5–7]. Such a dynamic state is broadly
consistent with the tunable activation threshold model
originally proposed by Grossmann and Paul [8] and may
allow for the persistence of autoreactive T cells that are
potentially useful against foreign antigens [9]. We have earlier
shown that this antigen adaptation primarily aims to restrict
the turnover of T cells in vivo to a minimal basal level, despite
the persistence of antigen [6]. The T cells that enter the
hyporesponsive state, however, have undergone signiﬁcant
differentiation and can produce effector cytokines at levels
higher than naı ¨ve T cells (albeit lower than memory T cells)
after an in vitro restimulation. This raises the possibility that
antigen-adapted T cells may continue to chronically display
effector functions against the persistent antigen despite the
restriction of their proliferative ability.
The downregulation of the proliferative potential of helper
T cells, while maintaining their ability to mediate effector
functions, has been reported in the case of T cells surviving
an acute antigen exposure in the absence of adjuvant [10]. In
this model, the tolerizing antigen does not persist and
therefore the effector potential of the T cells is unlikely to
be stimulated to induce pathology. It is therefore not clear if
continued persistence of antigen would result in the
elimination of the T helper cell’s effector function as well.
Furthermore, CD8
þ T cells that undergo adaptation to
chronic lymphocytic choriomeningitis virus (LCMV) infec-
tion or a self-antigen downregulate both their proliferative
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PLoS BIOLOGYand effector functionalities [11,12]. In this case, the ability to
produce interleukin (IL)-2 was often downregulated rapidly,
while various effector functions required extended stimula-
tion through chronic viral exposure [13]. CD8
þ Tc e l l s
experiencing chronic antigen in a transgenic model, however,
retained the ability to mediate cytolytic activity in vivo
despite anergy induction [14]. In the early phases of a chronic
LCMV infection, CD4
þ T cells speciﬁc for the virus were able
to help antigen-expressing (infected) B cells polyclonally,
leading to serum hypergammaglobulinemia [15]. This anti-
body production correlates with the acute viremia and
suggests that after several weeks of chronic viral infection,
CD4
þ T cells lose the ability to help B cells [16]. Nonetheless,
the ﬂuctuations in the antigen load due to viral replication,
clearance and tissue redistribution also makes such models
less suited to examination of the in vivo functionality of
stably antigen-adapted T cells.
We have previously described a model system for adaptive
tolerance that uses transgenic mice constitutively expressing
the antigen pigeon cytochrome C (PCC), driven by the MHC
class I promoter and an Ig enhancer, in a variety of cellular
compartments, including B cells and dendritic cells [6,7,17].
Antigen-speciﬁc naı ¨ve CD4
þ T cells adoptively transferred
into such mice crossed onto a CD3e
 /  background, adapt to
the persistent antigen over the period of a week. In the
absence of other competing T cells, these CD4
þ cells persist
for extended periods of time in the adaptively tolerant state
and show no evidence of having acquired a T-reg phenotype
[6,7]. This system, therefore, allows us to examine the
consequence of antigen adaptation on the T cell’s ability to
mediate effector functions in response to the ambient
stimulation, for example, by helping B cells that express
and present the cytochrome C antigen.
In this report, we demonstrate that the CD4
þ T cell
expansion to the persistent self-antigen results in a polyclonal
antibody response by the resident B cells. The antibodies are
directed against a variety of self-antigens classically impli-
cated in autoimmune disorders. The mice eventually develop
a mild form of chronic arthritis. Interestingly, CD4
þ T cells
that were ﬁrst stably adapted to the antigen in the absence of
B cells still retained the ability to help B cells and to cause
autoimmune disease. In contrast, in the presence of an
endogenous repertoire of T cells, the ability of the autor-
eactive T cell to induce pathology was severely compromised.
This tolerance was correlated with a failure of the transferred
transgenic T cells to complete effector differentiation and
survive in the T cell–replete host. Overall, these data
demonstrate that at least two distinct mechanisms—one cell
intrinsic and the other in trans—must cooperate to ensure
complete peripheral tolerance.
Results
Adaptation Controls Autoreactivity Independent of
Suppression
The exposure of naı ¨ve helper T cells to chronic peripheral
antigenic stimulation leads to a reversible state of anergy
known as adaptive tolerance. We have previously modeled
this process by adoptively transferring Rag2-deﬁcient 5C.C7
TCR transgenic T cells into CD3e knockout mice that express
membrane-targeted PCC under the control of an H-2K
promoter and an Ig enhancer [17]. After a robust initial
expansion, the transferred T cells downregulate their ability
to make cytokines to an in vitro restimulation and fail to
clonally expand well upon retransfer into a fresh
mPCC,CD3e
 /  host [6,7].
Proliferative impairment in peripheral T cells after
autoantigen encounter has often been attributed to the
induction of a regulatory phenotype in T cells [18,19]. Since
t h eh o s tm i c ei no u re x p e r i m e n t sd on o th a v ea n y
endogenous T cells, by design (CD3e
 / ), we examined if the
adaptively tolerant 5C.C7 T cells acquired a regulatory
function in the host. As shown in Figure 1A, we could not
detect foxp3 expression in the transferred cells at any time
that we tested (days 4, 11, 22, and 28, of which day 11 is shown
in Figure 1A, bottom row). Regulatory activity may still act
through a foxp3 independent fashion, but would be expected
to either impair the proliferation or differentiation of a new
T cell response [20]. We tested this by adoptively transferring
fresh Ly5.1
þnaı ¨ve 5C.C7 T cells into mPCC,CD3e
 / mice that
already harbored Ly5.2
þ 5C.C7 T cells in an adaptively
tolerant state. The resident population was unable to impair
the ﬁrst 3 d of expansion of the fresh naı ¨ve cohort (Figure 1B,
days 1–3). After this time, the new cohort did not expand
signiﬁcantly and could be recovered at similar numbers to
that in a lymphopenic host (solid squares in Figure 1B).
Finally, in order to examine if the differentiation of the
second cohort was impaired by the presence of adaptively
tolerant 5C.C7 T cells, we puriﬁed the expanded second
cohort (Ly5.1
þ, 5C.C7) by FACS sorting. The sorted cells were
assayed for their ability to produce interferon (IFN)c after in
vitro restimulation. Ly5.1
þ 5C.C7 T cells that expanded in the
presence of adapted Ly5.2
þ 5C.C7 T cells (solid triangles in
Figure 1C) or in an empty mPCC,CD3e
 /  host (open squares
in Figure 1C) had differentiated similarly as evidenced by
effector cytokine production in vitro. These data suggest by
multiple criteria, that adaptive tolerance in this model, is a
cellular phenomenon distinct from suppression. It is also
independent of clonal deletion, since the adaptively tolerant
T cells are not eliminated in the mPCC,CD3e
 /  host for the
life of the animal—solid squares in Figure 1B. Therefore, our
model system allows for a direct evaluation of the impact of
antigen adaptation on systemic immunological tolerance,
unlike many other models in which multiple paradigms
cannot be resolved sufﬁciently.
Adaptation Alone Is Insufficient to Generate Systemic
Tolerance
The mPCC,CD3e
 /  mice that harbor the tolerant PCC-
reactive 5C.C7 T cells do not display any obvious signs of
acute graft versus host disease such as weight loss, lethargy,
paralysis, or lethality. Interestingly, however, we began to
observe swelling of the hindlimbs and forelimbs of a few mice,
almost 2 mo after the adoptive transfer. These phenotypes
were observed only in the PCC transgenic recipients and not
in control CD3e
 /  mice, despite a weak ‘‘homeostatic’’
expansion of the 5C.C7 T cells, reported earlier [6]. To
further characterize this phenotype, we examined the animals
by x-ray imaging (Figure 2A and 2B) and Immunohistochem-
istry (Figure 2C–2E). Radiographs of the forelimb of an
adoptive transfer recipient at day 86 showed bone loss with
signiﬁcant distortion of the phalanges (Figure 2A, right)
relative to a control mouse (Figure 2A, left). The hindlimb
(Figure 2B) also showed increased bone density especially
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 /  mice
that were infused with autoreactive T cells 14 d earlier (Figure
2D) or 60 d earlier (Figure 2E) were stained by HEMATOX-
YLIN AND EOSIN after decalciﬁcation and sectioning. The
sections show the increased swelling at 60 d (Figure 2E)
compared to both the control (Figure 2C) and the 14-d time
point (Figure 2D). The legs were extended maximally before
being processed for sections and the lack of extension in the
day 60 leg is also evident in Figure 2E. Furthermore, mild
mononuclear cell inﬁltrates in the tibiotarsal regions were
evident in magniﬁcations of the day 60 sections (Figure 2E,
bottom). These ﬁndings suggested that an arthritic process
was developing in the 5C.C7 transfer recipients, despite the
induction of adaptive tolerance in these T cells. This was
surprising since the B10.A strain is not related to genotypes
that are conventionally associated with the ability to develop
arthritis, even after collagen immunization [21]. Although the
severity of the pathology did not approach that of some
arthritic models [22,23] or signiﬁcantly hamper feeding or
movement of the mice, we developed a scoring system to
quantitate this swelling (described in Materials and Methods).
Subtle alterations in joints or digits were visible in a few mice
as early as 24 d after transfer and progressively increased over
time (Figure 2F). Although not completely penetrant, up to
80% of the transfer recipients developed disease scores over
5 in less than 2 mo.
Polyclonal Activation of B Cells Drives an Autoreactive
Response during Adaptive Tolerance Induction
T cell–initiated autoimmune syndromes in mouse models
often require B-cell–mediated antibody production or anti-
gen presentation [24]. We examined whether this was the case
in our model system, by assaying serum antibody levels in
PCC transgenic mice at various days after the transfer of
5C.C7 T cells (Figure 3). The total amount of IgM in the serum
had increased to approximately 5-fold by 21 d of 5C.C7 T cell
transfer (Figure 3A, p , 0.0001 comparing normal serum
values at day 0 with day 21 after T cell transfer). This
increased level was maintained stably up to 200 d after the
initial transfer. A similar pattern was observed for total
amounts of IgG1 (Figure 3B), IgG2a (Figure 3C), IgG2b
(Figure 3D), IgG3 (Figure 3E), and IgE (Figure 3F). All
increases were statistically signiﬁcant over the levels detected
in control mice (on day 21, p¼0.0024 for IgG1, p , 0.001 for
IgG2a, p , 0.001 for IgG2b, and p ¼ 0.01 for IgG3). The
increase in these isotypes, however, was more dramatic,
Figure 1. Adaptive Tolerance Can Be Induced Independently of Regulatory Activity
(A) Intracellular staining with antibodies to foxp3 (left panels) or an isotype-matched control (right panels) on naive 5C.C7 T cells (middle two panels) or
antigen-adapted T cells (bottom two panels). Positive control staining in a polyclonal population of B10.A T cells marks approximately 19% of the CD4
þ
T cells (top two panels).
(B) A new cohort of naive 5C.C7 T cells expands similarly in B10.A, PCC
þ/þ, CD3e
 /  hosts (open squares) even if they already harbor expanded 5C.C7 T
cells (solid squares). Newly transferred 5C.C7 T cells were distinguished from the previous population using congenic markers (Ly5.1).
(C) Congenically marked Ly5.1
þ/þ,5C.C7 T cells that expanded in a naive B10.A, PCC
þ/þ, CD3e
 /  host (open squares) or a PCC
þ/þ, CD3e
 /  host that had
been injected with Ly5.2
þ/þ,5C.C7 T cells 28 d in advance (solid squares) were purified by FACS sorting (Ly5.1þ, CD4þ) and restimulated in vitro to
measure IFNc secretion.
DOI: 10.1371/journal.pbio.0040340.g001
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cell infusion [open circles in (A)–(E), * indicates samples with
undetectable levels]. The increase was also antigen speciﬁc
since we did not see a comparable increase in Ig levels after
the transfer of 5C.C7 T cells to B10.A,CD3e
 /  mice that did
not express PCC (unpublished data). The global increase in
the amounts of all of these isotypes shows that there is no bias
toward any ‘‘class’’ of immune response. This is also
consistent with our earlier report of a global suppression of
cytokine production in the adaptively tolerant T cells,
without skewing toward any particular subset or class of
response. The levels of IgA, however, were distinct from those
of all the other isotypes (Figure 3G). There was no increase in
the fecal levels of IgA (triangles) after T cell transfer, and
there was a reproducible decrease in the basal IgA levels
detected in the serum (solid circles). Consistent with
increased antibody production in these mice, we could also
detect an increased amount of circulating antigen-antibody
complexes as measured by a complement (C1q) binding
ELISA (Figure 3H).
We also examined the reactivity of antibodies generated in
this system against a panel of mouse antigens. Antibodies
could be detected against double-strand DNA (Figure 3I) as
well as ribosomal antigen extracts (unpublished data). The
levels of anti-DNA antibodies in the serum of mice 56 d after
5C.C7 transfer were signiﬁcantly enhanced over control mice
in all three isotypes tested: IgM (p¼0.01), IgG2a (p¼0.02), and
IgG2b (p¼0.02). Sera from transfer recipients were tested on
Western blots for reactivity against puriﬁed antigens.
Although the private reactivities varied between individual
mice (Table 1), most animals produced detectable antibodies
against multiple antigens, including histones, glucose-6-
phosphate isomerase (GPI), ﬁbrinogen, and collagen. Occa-
sionally, antibodies could also be detected against PCC,
consistent with the idea that B cells in this transgenic are not
completely tolerant of PCC, in the presence of T cell help
[25].
This broad spectrum of anticellular antibodies was also
evident in immunoﬂuorescence assays on test sections of
healthy murine kidneys (Figure 3J–3N). Sera obtained 4 wk
after transfer consistently (n ¼ 22 mice) showed reactivity
against cellular antigens. The staining showed a speckled
subnuclear reactivity (shown by higher magniﬁcation in
Figure 3O) that is consistent with patterns reported from
mice demonstrating autoimmune B-cell pathology, including
SLE. It is also noteworthy that although the total Ig levels
were almost maximally induced by day 10 (Figure 3A–3F),
there were no detectable anticellular antibodies until after 4
wk (Figure 3M). Thus, there was a qualitative change in the
antibodies being made at later time points, even after the
amount of secreted antibody had peaked (Figure 3K–3N
shows progressive changes in reactivity).
The Help for B Cells Is Available Even after the Stable
Induction of Adaptive Tolerance
The antibody responses observed in the 5C.C7 transfer
recipients could have been triggered by the robust, early
(days 1–4) expansion of naı ¨ve T cells in the mPCC,CD3e
 / 
host (Figure 1B, open squares), because stable adaptation to
antigen (as measured by cytokine downregulation) takes
approximately 1 wk to establish in this system [26]. We
therefore devised an experimental strategy to test if T cells
Figure 2. Adoptively Transferred T Cells Induce Arthritic Pathology in
Recipient Mice
(A) X-ray radiographs of fore limbs and (B) and hind limbs comparing
mPCC,CD3e
 /  mice without a T cell transfer (left panels) and one 86 d
after (right panels).
(C–E) Hindlimbs from mPCC,CD3e
 /  mice were sectioned and stained
by HEMATOXYLIN AND EOSIN before (C) T cell transfer and 14 d (D) or 60
d (E) afterward. Lower panels show magnification of the joint regions
from the top panels, to illustrate cellular infiltrates in the tibiotarsal
region.
(F) Clinical scores quantitate increased limb pathology in transfer
recipients on a scale of 0 to 56. Bars represent arithmetic means in
each group.
DOI: 10.1371/journal.pbio.0040340.g002
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T Cell Tuning and ToleranceFigure 3. Polyclonal B-Cell Activation and Autoantibody Production following the Induction of T Cell Adaptive Tolerance
(A–G) Total serum antibody levels of individual isotypes, measured by sandwich ELISA at different days after T cell transfer (solid circles). Open circles at
time 0 represent serum measurements from normal mice, without T cell transfer. *Serum samples where the levels of the isotype was below detection
[for two, four, three, three, and six samples each in (B), (C), (D), (E), and (F)]. Data in (A–E) are combined from two experiments between 4 and 60 d and
two additional experiments at later time points, with two to five mice per experimental group. Three additional experiments between days 7 and 120
gave similar results. Data in (F) and (G) are from two separate experiments with three mice per time point. Serum IgA levels were below our limit of
detection after the day 3 time point as indicated (*). Solid triangles in (G) represent measurements from solubilized fecal pellets. Note that the y-axes are
scaled differently for (A), (F), and (G) to accommodate different absolute amounts of IgM, IgE, and IgA.
(H) Increased circulating immune complexes in the serum after T cell transfer, demonstrated by a C1q binding ELISA. Each data point represents an
individual mouse, whose sera were all sampled on the same day after receiving T cells at various prior times (x-axis).
(I) Titers of anti-DNA antibodies in the sera of 16 individual T cell transfer recipients sampled in two separate experiments. Optical density values
obtained from isotype specific ELISAs for IgM (solid circles), IgG2b (solid squares), and IgG2a (solid triangles) are shown. Empty circles (IgM), squares
(IgG2b), and triangles (IgG2a) on day 0 represent sera obtained from three normal mice, assayed in the two experiments.
(J–O) Sera from mPCC,CD3e
 / mice were assayed for anticellular antibodies of the IgM (green) and IgG (red) isotypes, by hybridizing with frozen tester
sections of B10.A,Rag2
 /  kidneys. Numbers in the inset denote days after T cell transfer. (O) shows an enlarged area from (N) to illustrate speckled
nuclear staining. (J) was probed with serum from a normal mPCC,CD3e
 / mouse without T cell transfer. Similar sera samples from mice 4 d (n¼3) or 7 d
(n¼2) after T cell transfer did not show measurable IgG or IgM anti cellular antibodies. However, all mice tested after 28 d (n¼22) scored positive for
both IgG and IgM antibodies to various extents.
DOI: 10.1371/journal.pbio.0040340.g003
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induction of adaptive tolerance. We took advantage of the
fact that naı ¨ve 5C.C7 T cells can be induced into a stable
adaptively tolerant state in the absence of B cells, by using
an mPCC,Rag2
 /  host for the adoptive transfers. (N. J.
Singh, L. Chiodetti, and R. H. Schwartz, unpublished results).
We waited 48 d after transfer of T cells into such hosts and
then transferred 25 million naı ¨ve B cells intravenously
(Figure 4). B cells were puriﬁed from the spleens of
mPCC,CD3e
 /  mice (that express the antigen) or control
CD3e
 /  mice (that do not express PCC). Transfer recipients
were bled at various days after B-cell transfer and serum
immunoglobulins measured in an isotype-speciﬁc manner
(Figure 4A–4E).
Serum IgM levels in the transfer recipients increased
steadily after B-cell transfer, and there was only a subtle
increase afforded by antigen expression in the transferred B
cells (Figure 4A, solid triangles). In contrast, there were
signiﬁcant antigen-speciﬁc increases in IgG1 (p , 0.001 on
day 14) and IgG2a levels (p , 0.001 on day 14) only observed
in the presence of adapted T cells (Figure 4B and 4C). In the
case of IgG2b, although there was a 5- to 10-fold increase in
antibody production with PCC-expressing T cells (Figure
4D, solid triangles), the transfer of B cells alone resulted in
increased total IgG2b levels in the absence of any T cells
(Figure 4D, open inverted triangles). However the antigen-
speciﬁc increase was still signiﬁcantly greater (p ¼ 0.05 on
day 14, Figure 4D, closed triangles). In the presence of
adapted T cells and antigen-expressing B cells, there was a
sharp increase in IgE levels as early as day 8 and a
consistently increased but lower level thereafter (Figure
4E, solid triangles). We could not detect IgE production in
the recipients of non–antigen-expressing B cells or in the
absence of adapted T cells (Figure 4E, open circles and
triangles). These data demonstrate that even 48 d after T
cell transfer into a self-antigen–expressing environment,
adaptively tolerant T cells retain the ability to robustly help
B cells in an antigen-speciﬁc fashion.
The increase in serum immunoglobulin levels in the T cell
reconstituted B10.A,mPCC,CD3e
 /  mice precedes the devel-
opment of both anticellular antibodies (Figure 3) and visible
arthritis (Figure 2). Therefore, it was still possible that the
adapted T cells would be unable to aid the complete transition
from increased serum titers to developing joint disease. We
examined this possibility by introducing PCC transgenic B
cells into mPCC,Rag2
 /  mice, 28 d after they had received a
5C.C7 T cell transfer. We then assayed serum anticellular
antibodies and arthritis in the recipients at various days. The
serum anticellular antibody levels in these mice were similar
to those of B10.A,mPCC,CD3e
 /  mice (compare Figure 4G to
Figure 4H). However, the arthritis (Figure 4I, solid triangles)
was clearly delayed, since no signiﬁcant joint swelling or
rigidity was observed up to 60 d after transferring B cells (88 d
after the T cell input). These mice did start to develop
measurable disease by 80þ d; however, the severity was less
than that of B10.A,mPCC,CD3e
 /  mice at 60 d after T cell
reconstitution (Figure 4I, solid squares). These observations
demonstrate that the antigen-adapted T cell population can
still facilitate the maturation of the B-cell response that leads
to the production of anti–self-reactive antibodies.
Adaptively Tolerant T Cells Mediate Help through
Cytokines and CD40–CD40L Interactions
T cell help to B cells is mechanistically delivered through
the secretion of cytokines (including IL-4, IL-5, IL-21, IFNc,
etc.) and the engagement of cell surface receptors (including
CD40). Since adaptation dampens TCR signaling in these T
cells [27], the expression of these molecules may also be
expected to be impaired. However, T cells have undergone
signiﬁcant differentiation to make effector cytokines by the
time they are rendered tolerant [6]. The help that we observe
could therefore result from either the low levels of effector
Table 1 Purified Antigens Separated by SDS-PAGE and Transferred to Nitrocellulose Membranes Were Probed with Serum Samples
(1:1,000 Dilution) from Mice Bled Various Days after T cell Transfer
Days after Transfer Reactivity to
PCC KLH Col Fib GPI His
         
10 þ       þ
21          
21   þ      
26         þ
26         þ
42 þ þ     þ
42 þ þ   þ þ
56   þ      
56   þ þ þ þ
56 þ þ þ þ þ
90   þ þ þ þ
120 þþþ þ þ þ
120 þþþ þ þ þ
160   þ      
160   þ     þ
160   þ     þ
The reactivity of antibodies from such sera against individual antigens is scored.
PCC, pigeon cytochrome c; KLH, keyhole limpet hemocyanin; Col, collagen; Fib, fibrinogen; His, histones.
DOI: 10.1371/journal.pbio.0040340.t001
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or alternatively by the unaffected synthesis of any one
component, which is resistant to the dampening effects of
adaptive tolerance. We tested these two possibilities by
knockout and blocking strategies designed to ask if any one
component was the dominant inducer of B-cell differ-
entiation in this model system.
The absence of IL-4 in the transferred 5C.C7 T cells (Figure
5A–5C, gray bars) resulted in less than 2-fold decrease in
serum IgG1 (p¼0.08, in Figure 5A) and IgG2b (p¼0.05, Figure
5C) levels. Similarly, IFNc knockout 5C.C7 T cells elicited
approximately 2- to 3-fold lower levels of IgG2a (p ¼ 0.006,
Figure 5B) with a slight increase in IgG1 (p ¼ 0.02). The
cytokine IL-21 has been reported to act as a Th2 enhancer or
plasma cell factor in differentiating B cells [28,29]. We used
mPCC,CD3e
 / mice that were also deﬁcient in IL-21 receptor
as transfer recipients to examine the contribution of this
cytokine to the hypergammaglobulinemia. The absence of IL-
21 responsiveness in B cells decreased serum levels of all
isotypes by 2- to 3-fold (Figure 5A–5C, last three bars in each
graph). Interestingly combining IL21R deﬁciency in B cells
together with IL-4 or IFNc deﬁciency in T cells did not
synergistically reduce serum Ig levels any further.
We then examined the role of CD40–CD40L interactions
using the mPCC,Rag2
 /  model described in the previous
section. Mice with resident adaptively tolerant T cells were
treated with blocking anti-CD40L antibody (MR1) or a
control antibody intraperitoneally (100 lg/mouse) at the
same time as introducing naı ¨ve PCC-expressing B cells
(Figure 5D–5F). The blocking antibody treatments were
continued every other day and the serum antibody titers
measured 14 d after B-cell transfer. In contrast to the
cytokine deﬁciency experiments, blocking CD40–CD40L
interactions resulted in a profound decrease in IgG2a and
IgG2b induction (Figure 5E and 5F). The decrease in IgG1 was
less pronounced but did show a 3- to 5-fold decrease. In a
separate experiment, CD40L blockade was carried out for
only a short period, from the time of B-cell transfer to 6 d
after. Twenty-two days following the last treatment (28 d after
B-cell transfer), IgG2a (Figure 5G) and IgG2b (Figure 5H)
Figure 4. Stable Adaptive Tolerance Does Not Abrogate the Ability of T Cells to Help Autoreactive B Cells
(A–E) Purified splenic B cells (25 million) were transferred into mPCC,Rag2
 / mice that received 5C.C7 T cells 48 d earlier. The amount of serum antibody
of each isotype 8, 14, and 21 d after the transfer of PCC transgenic B cells (triangles) or antigen-free B cells (circles) is plotted. Solid triangles and open
circles are measurements from mice that received 5C.C7 T cells 48 d before the B-cell transfer. Open inverted triangles are measurements from
mPCC,Rag2
 /  mice that did not receive T cells. Two other experiments, including one using FACS-sorted B cells, showed similar results.
(F–H) Antinuclear antibodies in the serum of mPCC,Rag2
 / mice 30 d after B-cell transfer (H). Three other mice from the same experiment also showed
anticellular reactivity. Similarly stained tester sections using serum from an mPCC,CD3e
 / mouse that received 5C.C7 T cells 60 d earlier (G) or a control
B10.A mouse (F) are provided for comparison.
(I) Arthritis development between 21 and 82 d after the transfer of mPCC
þB cells (triangles) into mPCC,Rag2
 / mice bearing adoptively tolerant 5C.C7 T
cells. Arthritis in mPCC,CD3e
 /  mice 60 and 82 d after receiving naive 5C.C7 T cells (squares: C 60, C 82) are scored for comparison.
DOI: 10.1371/journal.pbio.0040340.g004
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cells were still detected in the hosts. These experiments
suggest that B-cell help in this model is delivered by a
combination of soluble and surface molecules and is not a
consequence of a single, tolerance resistant factor or skewed
differentiation of the adapted T cells.
Despite Help, Autoimmune Pathology Does Not Develop
in a T Cell-Replete Host
The experiments so far clearly demonstrate that in a
carefully constructed model system where adaptive tolerance
is the only potential mechanism of tolerance to a peripheral
self-antigen, T cell effector functions sufﬁcient to mediate
autoimmune pathology are still evident. We then asked if this
pathology would still be initiated, if other mechanisms of
immunoregulation are restored to the model system. This was
tested by transferring congenic 5C.C7,Ly5.1
þ T cells to a
B10.A,mPCC (Ly5.2
þ) transgenic mouse that retained an
intact repertoire of endogenous T cells (CD3e
þ/þ). Serum
from these transfer recipients also showed a consistent
increase in IgG1 (Figure 6A), IgG2a (Figure 6B), and IgG2b
(Figure 6C) levels. The titers of these antibodies, however,
were approximately 5- to 10-fold lower than that observed in
a T cell–deﬁcient host (compare to Figure 3). Furthermore,
the T cell–replete transfer recipients did not develop
detectable titers of anticellular antibodies (Figure 6F)
compared to the T cell–deﬁcient host (Figure 6E). Consistent
with these lowered titers and absence of anticellular anti-
bodies, the transfer recipients that had an intact cohort of
endogenous T cells did not develop detectable arthritic
pathology even 120 d after T cell transfer (Figure 6G).
5C.C7 T Cells Are Anergic in a T Cell–Replete Host, but Do
Not Undergo Differentiation toward Effector Function
Given the striking difference in pathology observed in the
presence or absence of endogenous T cells, we further
dissected the fate of 5C.C7 T cells in the T cell–replete host.
The transferred cells engrafted similarly in the T cell–replete
host and initiated clonal expansion (Figure 7A, open
squares). However, this expansion lasted only for 3 d and
resulted in just a 5-fold increase in cell number. This was a
consequence of a failure to sustain cell divisions, as
evidenced by the carboxy ﬂuorescein succinimidyl ester
proﬁles (Figure 7B). Furthermore, the expanded T cells
underwent a slow deletion process in the T cell–replete host,
starting at day 4 and resulting subsequently in a approx-
imately 3.5% per day loss of the expanded cells. This resulted
in the reduction of the T cell numbers to below detection
levels by approximately 2 mo. This disappearance phase was
in sharp contrast to the fate of the autoreactive CD4
þ T cells
Figure 5. Cytokine and CD40L Dependence of Help Rendered by Adaptively Tolerant T Cells
(A–C) Serum from mice that received T cells 8 d before were assayed for total immunoglobulins as described. T cells were from 5C.C7 TCR transgenic
mice (white bars) or similar mice also deficient in IFN-c (black bars) or IL-4 (gray bars). Host mice were mPCC,CD3e
 / (left three bars in each graph) or IL-
21 receptor–deficient mPCC,CD3e
 /  mice (right three bars).
(D–F) B cells were infused into mPCC,Rag2
 /  mice that harbored stably adapted 5C.C7 T cells. The blocking anti-CD40L antibody MR1 (black bars) or a
control hamster antibody (white bars) was administered at the same time and on every other subsequent day for 13 d, before assaying serum for
antibody titers.
(G, H) Similar experiments (as in D–F) were carried out, but the blocking antibody treatment was terminated at 6 d. Twenty-two days afterward, serum
IgG2a (G) and IgG2b (H) levels were measured in the MR1 treated (black bars) or control (white bars) mice.
DOI: 10.1371/journal.pbio.0040340.g005
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 /  (T cell–deﬁcient) PCC transgenic host (Figure
7A, solid squares), which persisted for several months.
We then asked if an adaptively tolerant form of anergy
was in fact induced in the 5C.C7 T cells in the T cell–replete
host, by measuring IL-2 production and TCR proximal
signal transduction. Sorted 5C.C7 T cells 15 d after adoptive
transfer into a B10.A,mPCCþ host showed an 85% down-
regulation of IL-2 secretion (Figure 7D, gray bar, compared
to naı ¨ve T cells in white bar) similar to the 93% down-
regulation in a CD3e
 /  host. Over ﬁve separate experiments,
5C.C7 T cells in a T cell–replete host showed an 85 6 3.5%
decrease in IL-2 production relative to naı ¨ve 5C.C7 T cells,
while in the lymphopenic host, this was 91 6 7%. The CD3
proximal signaling machinery of the cells in either host was
also tested by monitoring calcium inﬂux in response to
cross-linking with anti-CD3 ex vivo. The ﬂuxes elicited by T
cells from a T cell–replete host (Figure 7C, red trace) were
equally dampened in comparison to the ﬂuxes from those in
a T cell–deﬁcient host (Figure 7C, blue trace). Both were
impaired in comparison to naı ¨ve T cells (Figure 7C, green
line) as previously reported [27]. Therefore, the adaptive
tolerance induced in the 5C.C7 cells is T cell–intrinsic and
independent of the presence of an endogenous host
repertoire of other T cells.
Finally, we found that the adaptively tolerant 5C.C7 T cells
recovered from a T cell–replete host showed no signiﬁcant
differentiation towards effector cytokine production. Upon
restimulation in vitro, adaptively tolerant T cells from the
CD3e
þ/þ host (Figure 7E, gray bar) made the same small
amount of IFNc as undifferentiated naı ¨ve T cell cultures
(Figure 7E, white bar). T cells from a CD3e
 /  host showed
considerable differentiation to make this cytokine (Figure 7E,
black bar), although this was, as reported earlier, still greatly
impaired relative to a memory 5C.C7 T cell [7]. We further
conﬁrmed that autoreactive T cells fail to differentiate and
display effector functions in a T cell–replete host by assaying
for IFNc secretion ex vivo, using a cytokine secretion assay
(Figure7F).About11% oftheadaptivelytolerant 5C.C7 Tcells
were secreting this cytokine 4 d aftertransfer to a CD3e
 / host
(Figure 7F, left), whereas only 0.6% of the cells could be scored
positive in a CD3e
þ/þ host. Similar to the lymphopenic host,
5C.C7 T cells in the T cell–replete host did not express
detectable IL-4 or foxp3 or upregulate CD25, suggesting that
they had not differentiated into a Th2 or T-reg lineage (data
not shown). Therefore, although adaptive tolerance was
primarily induced in every context, a superimposing inﬂuence
of the endogenous T cells is critical to reduce the expansion,
effector differentiation and pathology stemming from autor-
eactive CD4
þ T cells.
Discussion
Anergy, deletion, and regulation have been proposed as
three mechanisms that the adaptive immune system uses to
tolerize CD4
þ T cells reactive to peripheral self-antigens
[4,30,31]. The relative signiﬁcance of each of these processes
to systemic tolerance and their synergism in vivo has been
difﬁcult to dissect, despite the existence of many model
systems. It is formally possible that all of these mechanisms
are in fact inseparable elements of a uniﬁed tolerance
process. For example, the facts that regulatory cells display
evidence of anergy and that anergic cells have been shown
to regulate could be interpreted as evidence of similar
biochemical machinery operating in both conditions. The
conditions of assay or the quantitative gradation of the
biochemical process may reveal anergy, regulation, or both.
Therefore, it is critical to begin to separately quiz the roles
of individual processes in peripheral tolerance and to
decipher the network of interactions between these pro-
cesses in vivo. This report represents a comprehensive
examination of the role of in vivo anergy (adaptive
tolerance) in the maintenance of peripheral tolerance. The
adoptive transfer strategy we have used mimics the
stimulation of a naı ¨ve T cell with a peripheral self-antigen
or a chronic pathogen, albeit a systemic one. In most model
systems, these responses are inﬂuenced by various noncell
autonomous factors such as regulatory T cells, Th2 or Th3
cells, NK T cells, cd T cells, etc. The absence of these other
endogenous T cells in the recipient we have used (CD3e
 / 
host) limits the regulatory mechanisms available to those
intrinsic to the responding T cell population. We also
eliminated the induction of trans-regulatory phenotypes
within the population we have introduced, as has been
found in other models [19,32]. Thus, our data clearly
demonstrate that while tuning effectively constrains clonal
expansion and quantitatively buffers cytokine synthesis, it is
Figure 6. Autoantibodies and Arthritis Do Not Develop in the Presence
of Polyclonal Endogenous T Cells
(A–C) 3 million Ly5.1
þ,5C.C7 T cells were transferred into mPCC
þ/þ(T cell–
replete) mice that had an intact repertoire of polyclonal T cells. Serum
antibody titers were measured at various days after transfer. Total IgG1
(A), IgG2a (B), and IgG2b (C) levels are shown (filled circles). Inverted
open triangles represent titers before T cell transfer. Data are pooled
from two separate experiments with two to five mice per time point.
Similar results were obtained in two other experiments.
(D–F) Serum from T cell–replete (F) or T cell–deficient (E) PCC transgenic
mice were used to stain tester B10.A,Rag2
 /  kidney sections at 1:100
dilution. Staining with control serum from a normal B10.A mouse is
shown in (D).
(G) Development of arthritis scored in the T-replete mPCC transgenic,
5C.C7 transfer recipients.
DOI: 10.1371/journal.pbio.0040340.g006
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autoreactive T cells, two parameters that could very well be
linked [33]. These parameters must be constrained by other
non–cell-intrinsic regulators, so as to completely eliminate
pathology.
The conclusions of this study are supported by earlier
arguments that anergic T cells can help B cells generate a Th1
(IgG2a) class of response [10]. Those data, however, were
consistent with the ‘‘overcoming’’ of anergy by a stronger
antigenic challenge. In contrast, the helper activity in our
model is continual and does not require an antigenic
challenge exceeding the level of ambient presentation.
Furthermore, the differentiation in this system does not skew
the responses toward any particular class of antibody
production. Antibodies typically associated with Th1 (IgG2a)
as well as Th2 (IgG1 and IgE) helper function were all
upregulated. The increased Ig levels did not just reﬂect
speciﬁc antibody production against the cognate antigen
(PCC, which was absent in most mice) but was of diffuse
polyclonal reactivity (Figure 3). This is not surprising, since
the expression of PCC under the control of the MHC-I
promoter and Ig enhancer should result in antigen expression
in all of the B cells [7,17]. Endogenous membrane bound
antigens have been shown to gain access to the class II pathway
during membrane recycling or by autophagy [34–36]. This
should allow all B cells in this model system to express PCC
peptide–MHC complexes and thus interact with the 5C.C7 T
cells independent of the B cell’s own receptor speciﬁcity. This
in turn would generate an efﬁcient mechanism for providing
T cell help to any B cell whose Ig receptors also engaged their
cognate antigen, including abundant self-antigens that might
normally rely on the absence of T cell help to prevent
autoantibody generation. In fact, among the antibodies
generated in our system, some were reactive against DNA,
histones, and GPI molecules implicated in B-cell–mediated
autoimmune disorders like arthritis or lupus in other mouse
model systems [37]. The transfer recipients in our model
progress toward a mild form of arthritis (Figure 3). This
disease did not develop in the absence of B cells (Rag2
 / PCC
þ
transfer recipients) at least up to 110 d after T cell transfer
(data not shown). Although the simplest interpretation of
these data would be that T cell–dependent antibody produc-
tion is the etiologic agent in the disease process, we have not
excluded the possibility that the presence of B cells in the
system merely enhanced a pathologic T cell response in this
model. In preliminary experiments transfer of serum from
arthritic mPCC,CD3e
 /  mice to mPCC,RAG2
 /  mice did not
result in the induction of arthritis in the recipients (unpub-
Figure 7. Poor Differentiation and Survival Are Superimposed on Adaptive Tolerance in the Presence of Endogenous T Cells
(A) The total recovery of Ly5.1
þ 5C.C7 T cells from lymph nodes and spleen of recipient mice, various days after transfer into a T cell–replete
(mPCC
þ,CD3e
þ; open squares) host are compared with the recovery from a T cell–deficient (mPCC
þ,CD3e
 /  ; filled squares) transfer recipient.
(B) Carboxy fluorescein succinimidyl ester profiles of transferred Ly5.1
þ 5C.C7 T cells, 3 d after transfer into a lymphopenic (top) or T cell–replete
(bottom) PCC transgenic host.
(C) Ly5.1
þ,5C.C7 T cells, recovered 9 d after transfer to a T cell–replete PCC transgenic (red line) or T cell–deficient PCC transgenic (blue line) host, were
loaded with Indo-1 and stimulated as described in Materials and Methods. The influx of calcium, measured as the ratio of violet to blue fluorescence, is
compared to that of naı ¨ve 5C.C7 T cells (green line).
(D) IL-2 or (E) IFN-c secretion from sorted Ly5.1
þ,5C.C7 T cells restimulated in vitro with 10 lM MCC peptide and irradiated syngeneic splenocytes for 48
h, 15 d after residence in a T cell–replete (gray bars) or T cell–deficient (black bars) PCC transgenic hosts. Naı ¨ve 5C.C7 T cells (white bars) were used for
comparison.
(F) Ex vivo IFNc secretion by transferred T cells recovered 4 d after transfer to a T cell–replete (right) or T cell–deficient (left) PCC transgenic host. FACS
plots are gated on CD4þ, 7AAD-ve cells in the lymphocyte area.
DOI: 10.1371/journal.pbio.0040340.g007
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mPCC,RAG2
 /  recipients the plateau levels of 5C.C7 T cells
are approximately 4-fold lowerthan that inthe mPCC,CD3e
 / 
host. Nonetheless, the disease process is clearly T cell initiated,
whether through helping B cells or triggering other inﬂam-
matory cascades in the innate immune system [37,38]. In
either case, it reﬂects continued effector responses from the
peripherally ‘‘tuned’’ T cells.
Importantly, the B-cell–deﬁcient system was useful to show
that continued help is available to B cells even after the T
cells have adapted (Figure 4). Interestingly, the arthritic
pathology in this case was delayed by over a month and even
then signiﬁcantly reduced compared to that in the CD3e
 / 
host (Figures 2F and 4I). Again, although it is arguable that
the delay in pathology represents a consequence of anergy
induction, we cannot rule out the possibility that this was due
to the 4-fold lower number of anergic T cells or the absence
of continued B-cell generation in the same host resulting in a
reduced ‘‘repertoire’’ of B cells. The ability of the B cells to
receive help is still very surprising, given our earlier report
that dendritic cells isolated from this antigen transgenic
mouse present higher levels of antigen than resting B cells in
an in vitro T cell proliferation assay [7]. One might have
predicted that a quantitative adaptation to the level of
antigen presentation by dendritic cells should have abrogated
the T cell’s ability to productively sense any antigen on B
cells. Or observations therefore argue against quantitative
receptor calibration being sufﬁcient as a tolerance mecha-
nism, at least for a high-afﬁnity receptor–ligand pair in the
periphery.
The ability of a broad repertoire of B cells to present
antigen makes our system comparable to models of persistent
viral infection, like the LCMV model. Interestingly, such
infections also induce a polyclonal hypergammaglobulinemia
that is strictly dependent on viral antigen-speciﬁc T cell help
[15]. Virus-speciﬁc helper T cells during chronic infections
also enter an anergic state within 2 wk and, in seeming
progression of the adaptation, subsequently lose the ability to
prime de novo B-cell responses [15,39]. This difference from
our results might stem from intrinsic differences in the model
systems. These include the generation of antibody escape
variants due to viral replication, the presence of virus derived
TLR ligands, and the possibility that constant ﬂuxes in
antigen dose may recruit mechanisms other than tuning to
regulate immunopathology [40–42]. Furthermore, the use of
mice with an intact repertoire of T cells in the LCMV
infections allows for non–cell-autonomous regulatory mech-
anisms to be superimposed on the adaptive tolerance process
(as we discussed earlier). Nonetheless, it is interesting to note
that even during persistent viral infections, CD4
þ T cells are
required for effective control of the virus [43,44]. In cases
where chronic viral infections have been shown to abrogate
effector functions in CD8
þ T cells, the viremia is still
constrained progressively and the virus distribution localized
to restricted tissues, arguing that biological activity in the
CD4
þor CD8
þcells is being maintained despite the persistent
infection [13]. These experiments, however, need to be
reexamined in the absence of thymic output and trans-
regulatory cells, using adoptive transfer systems similar to the
one we have used.
The restoration of an intact polyclonal T cell compartment
in our experimental model (Figures 6 and 7) was sufﬁcient to
constrain the autoimmune pathology that we observed. This
allowed us to investigate the cellular paradigm that needs to
superimpose on adaptive tolerance, in order to achieve
‘‘complete’’ tolerance. Interestingly, although adaptive toler-
ance (decreased TCR signaling and IL-2 production) was
induced to equal extents without regard to the presence of
other T cells, the subsequent elimination of autoreactive T
cells only happens in the presence of other endogenous T
cells. These data demonstrate that while anergy is chosen as a
primary, cell-intrinsic fate, following tolerogenic antigen
encounter in the periphery, the subsequent ‘‘deletion’’ is
unlikely to be cell autonomous. The nature of the T-T
interaction that results in the slow decay of the anergic T cell
population is under investigation. Preliminary experiments
using anti-CD25 and anti–IL-2 treatment to deplete CD25
þ T
cells in the T cell–replete host suggest that such cells are
unlikely to be sufﬁcient to mediate this process. Alternatively,
we favor a trophic competition process similar to the one that
has been described for B cells [45]. The process is likely to be
more than a mere competition for ‘‘space,’’ since preliminary
experiments suggest that simply ﬁlling up the animal with a
second TCR transgenic CD4þ population is insufﬁcient to
eliminate the adapted 5C.C7 T cell. However, the recent
demonstration that clonal competition between T cells can
affect proliferation and survival in vivo may be relevant to the
control of autoimmune pathology in this regard [46,47]. A
similar paradigm may also operate in the case of CD8þT cells
that are rendered tolerant to self-antigen [48].
Unlike thymic negative selection or activation-induced cell
death, the ‘‘deletional’’ component of peripheral T cell
tolerance seems to be a relatively slow process. While the
reduction of T cell numbers as a result of it is indeed quite
striking, it still does not prevent the persistence of a large
number of autoreactive T cells in the animal for up to 2 mo.
Thus, even in the T cell–replete host, the adaptive tolerance
component must play a critical role in constraining the
renewed recruitment and expansion of the high afﬁnity
autoreactive T cells. In addition, the inability of these CD4
þT
cells to fully turn on autoreactive B cells likely stems from the
profound blockade in the differentiation of these cells in the
T cell–replete host. T cell differentiation to acquire effector
functions have previously been correlated with the extent of
cell division [49]. The limited initial expansion of the T cells
could therefore lead to poor expression of effector molecules
(including IL-4, IFNc, IL-21, and CD40L) and handicap the
ability of adapted T cells to help B cells. Such an impairment
of effector differentiation (and migration) of pathogenic T
cells can also be achieved by the action of trans-regulatory T
cells as observed in other model systems [50,51].
Multiple theories have debated the merit of singular
mechanisms that maintain peripheral tolerance (reviewed in
[52]). Models of T cell tuning have argued that a quantitative
dampening of the T cell’s sensitivity to ambient antigen
should be sufﬁcient to prevent pathology [53,54]. The
maintenance of such cellular tuning requires that the cell
be constantly aware of the persistence of antigen. The
prevention of pathology, on the other hand, requires the cell
to avoid effector responses despite the constant interaction
of the receptor with a strong endogenous agonist. The success
of tuning as a tolerance mechanism therefore depends on the
ability of the T cell to walk this biochemical tightrope
efﬁciently. Our data would argue that over time, in the
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enough helper activity is able to break through, so as to
mediate visible systemic pathology. It is quite likely that this
inadequacy is not unique to the mechanism of adaptive
tolerance, because it has been argued that other mechanisms
of immune regulation, e.g., T-regs, also cannot control
autoimmunity in isolation [55]. Nonetheless, quantitative
dampening of TCR responsiveness (and the kinetic delay in
the onset of pathology that it might afford [Figure 4F]) could
in fact be quite critical in vivo, allowing additional regulatory
processes to effectively collaborate and enforce complete
peripheral tolerance [56].
Materials and Methods
Mice and cells. Mice used in this study were obtained through the
NIAID contract at Taconic Farms (Germantown, New York, United
States), an AAALAC accredited facility. All the mice used in these
experiments were bred on a B10.A (H-2
a) background and were
Ly5.2
þ/þunless otherwise noted. The 5C.C7,Rag2
 / ; mPCC transgenic;
CD3e
 / ; and mPCC,CD3e
 /  strains have been described [6,7].
mPCC,CD3e
 /  mice were crossed twice to Rag2
 /  animals selecting
for Rag2
 /  homozygotes, eliminating the CD3e-null allele and
intercrossed, to derive the B10.A,mPCC,Rag2
 /  strain. The
5C.C7,Rag2
 / ,Ly5.1
þ/þ strain was derived by crossing 5C.C7,Rag2
 / 
mice to B10.A,Ly5.1
þ/þ. The 5C.C7,Rag2
 / ,IL-4
 /  strain was a gift
from J. Zhu and W. E. Paul (NIAID, NIH, Bethesda, Maryland, United
States). The IFNc-deﬁcient allele was backcrossed onto the B10.A,5C.-
C7,Rag2
 /  background three times from a B6,IFN-c
 /  (N12) strain.
The B6,IL21R
 / mouse was obtained from R. Spolski and W. Leonard
(NIAID, NIH), crossed to the B10.A background four times, and
rendered homozygous for both the mPCC transgene and the CD3e
 / 
allele.
For adoptive transfer experiments involving T cells from 5C.C7
TCR transgenic mice, lymph node suspensions containing greater
than 90% CD4þ T cells (1 to 3 million per recipient) were injected
without further puriﬁcation into recipients by the suborbital route. B
cells were puriﬁed from the spleens of either B10.A,mPCC,CD3e
 / or
B10.A,CD3e
 /  mice using the mouse B-cell puriﬁcation kit (Miltenyi
Biotech, Auburn, California, United States) or sorted to greater than
98% purity after labeling with anti-B220 PE (BD Biosciences, San
Diego, California, United States). Twenty-ﬁve million puriﬁed B cells
were transferred in the experiments shown, but injections of up to 50
million B cells gave similar results.
In vivo blockade of CD40L was achieved by injecting 100 lg/d mAb
MR1 and compared with a control hamster IgG (anti-TNP), both
obtained as no azide/low endotoxin grade from BD Biosciences.
In vitro T cell cultures and functional assays. Transferred T cells
stained with anti-CD45.1 PE and anti-CD4 APC (BD Biosciences)
were sorted to greater than 99% purity using a BD Vantage or BD
Aria sorter at the NIAID ﬂow cytometry facility. Ten thousand
sorted T cells were cocultured with 2 to 5 3 10
5 irradiated
B10.A,CD3e
 /  splenocytes and titrations of Moth Cytochrome C
(MCC) 88–103 peptide (American Peptide Co., Sunnyvale, Califor-
nia, United States). Culture supernatants taken 48 h later were
assayed by ELISA for IL-2 and IFNc secretion as per manufacturer’s
instructions (R&D Systems, Minneapolis, Minnesota, United States).
Ex vivo analysis of cytokine secretion was carried out using the IFNc
secretion assay (Miltenyi Biotec) as previously described for IL-2
[57]. Analysis was restricted to viable cells based on the exclusion of
the vital dye 7-AAD (BD Biosciences). Intracellular foxp3 expression
was measured using the FKJ-16s staining kit (eBioscience, San Diego,
California, United States) per the manufacturer’s instructions.
Calcium responses in T cells were measured by loading cells with
5 lg/ml Indo-1 (Molecular Probes, Eugene, Oregon, United States) at
37 8C before stimulation. Loaded cells were washed in cold HBSS
containing 1 mM CaCl2 and 1 mM MgCl2, before labeling with
Ly5.1-PE and CD4-APC at 4 8C. The washed cells were brieﬂy
warmed to 37 8C before analyzing on a BD LSR II cytometer. After
30 s, prewarmed biotinylated anti-CD3 was added to a ﬁnal
concentration of 10 lg/ml, and 2 min later, a warm solution of
streptavidin (5 lg/ml ﬁnal) was added and the data were collected
for a further 400 s. Collected data were analyzed using the FlowJo
software (Treestar, Ashland, Oregon, United States).
Antibody measurements. Serum samples were assayed for various
antibodies using sandwich ELISAs. For determination of total
globulin levels, anti-mouse kappa or anti-mouse lambda (Caltag,
Burlingame, California, United States) was coated on NUNC
Maxisorp plates (Nalge Nunc, Rochester, New York, United States)
at 1 lg/ml concentrations in carbonate buffer (pH 9.0). Binding was
blocked with 0.25% BSA in Tris-buffered saline þ 0.1% Tween-20
(TBS-Tween). Serum dilutions made in TBS-Tween were incubated
with the plates and the bound antibodies detected with isotype-
speciﬁc antisera coupled to HRP (Caltag). The concentrations of each
isotype were calculated from a standard curve using puriﬁed Ig
isotypes (CaltagA). Anti-DNA antibodies were assayed similarly, after
coating with calf thymus DNA (10 lg/ml) instead of anti-lambda/
kappa.
Western blots. Puriﬁed proteins were loaded at 1 lg/well and
separated on a 5% to 12.5% PAGE gel (Bio-Rad, Hercules, California,
United States). Separated proteins were transferred onto nitro-
cellulose and bound with serum samples diluted 1:1,000 in TBS-
Tween. Bound antisera were detected with anti-mouse Ig labeled with
HRP (Bio-Rad).
Immunohistochemistry. Formalin-ﬁxed and decalciﬁed limb sam-
ples were mounted on parafﬁn blocks and sectioned to 15-lm
thickness before processing for hematoxylin and eosin staining. For
ANA analysis, healthy B10.A,Rag2
 / kidneys were cryosectioned onto
silanized slides by Histoserv Inc. (Gaithersburg, Maryland, United
States). Each slide had duplicate sections of such kidneys and were
ﬁxed in Histochoice solution (Amresco, Solon, Ohio, United States)
for 2 to 3 min. Nonspeciﬁc binding was blocked with 1% BSA and
donkey serum, followed by incubations with serum samples diluted
1:3,000. Bound antibody was detected with Fab fragments of donkey
anti-mouse IgM and donkey anti-mouse IgG, labeled with Cy3 and
FITC, respectively (Jackson ImmunoResearch, West Grove, Pennsyl-
vania, United States). Stained sections were scored as positive on a
Leica DMRX ﬂuorescent microscope if both duplicate sections on the
slide were stained positive. Images were collected using a CCD
camera and Slidebook software (Intelligent Imaging, Petaluma,
California, United States). The range of colors observed depended
on the relative amounts of IgM (red) and IgG (green) antibodies in the
tested serum that bind self-antigens in the kidney sections. Overlap of
red and green signals at high intensity resulted in the yellow colors on
the composite images.
Arthritic score. An arbitrary arthritic score was developed to
quantitate the extent of disease progression in the mice. Swelling in
individual digits was assigned a score of 1 (per digit) with an
additional score of 1 added if the digits were inextensibly curled up.
Thus each leg could get a maximum theoretical score of 10 based on
the health of the digits (counting the polex as the ﬁfth toe in the front
legs). Swelling of the feet and lower legs were assigned scores of one
each increasing the maximum score per leg to 12. In addition, the
inability to extend the elbow or knee joints fully was given a score of
one per leg, while the failure to extend this joint beyond a
approximately 45-degree angle was scored as 2. As a result, the
maximum score per animal in this system was 56 (14 3 4). The
shoulders and thighs were not scored in these mice.
X-ray imaging. Mice were killed and taped to ﬁlm before being
exposed to 30-kV x-rays for 55 seconds at the NICHD faxitron facility
(Bethesda, Maryland, United States).
Statistical analysis. All statistical analyses were done using the
unpaired, two-tailed Student’s t-test and Prism 4 software (Graph-
PAD, San Diego, California, United States).
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